 
   
                   
                                          
                                       
              | Feature | Specification | 
|---|---|
| Application | Newborn Screening | 
 
               
                                          
                                       
              If not diagnosed and treated within the newborn period, it can lead to diarrhea, dehydration, jaundice, hepatic failure, hypoglycemia, cataracts, developmental retardation, and death within a few weeks. Treatment of the disease consists of withdrawal of all foods containing lactose and galactose from the diet.
GSP Neonatal GALT - the first automated GALT assay
The GSP Neonatal GALT assay is used as an aid in screening newborns for classic galactosemia caused by GALT deficiency using the GSP™ instrument.
| Application | 
                      Newborn Screening
                   | 
|---|---|
| Brand | 
                      GSP®
                   | 
| Detection Modality | 
                      Enzymatic
                   | 
| Disorders | 
                      Galactosemia
                   | 
| Instrument Compatibility | 
                      GSP
                   | 
| Quantity | 1152 tests | 
| Regulatory Status | CE-IVD marked | 
| Sample Type | 
                      Dried blood spots
                   | 
| Technology | 
                      Enzymatic
                   | 
| Unit Size | 12 plates | 
Are you looking for resources, click on the resource type to explore further.
 
     
  We are here to answer your questions.
 
    